Shandong Wohua Pharmaceutical Co Ltd

Shandong Wohua Pharmaceutical Co Ltd maintains a strong liquidity position, with a current ratio of 2.35, indicating the company can cover its short-term liabilities with its short-term assets. The company's liquidity FPT (free cash flow to total debt) is robust, supported by a free cash flow of 49.44 million CNY and long-term debt of only 5.25 million CNY, suggesting minimal pressure on liquidity from debt obligations. Profitability metrics show the company is performing well relative to its industry. The return on equity (ROE) of 13.22% and return on assets (ROA) of 9.79% are strong, indicating efficient use of equity and assets to generate profit. The gross profit margin of 75.17% (613.89 million CNY gross profit on 816.95 million CNY revenue) is also robust, suggesting the company maintains a healthy margin structure. The company's revenue is concentrated in the domestic Chinese market, as disclosed in its business description, with no material international operations. This concentration may expose the company to regulatory and economic risks specific to China, but it also allows for focused market penetration and brand recognition. Looking ahead, the company's revenue is expected to grow, supported by a strong operating cash flow of 128.53 million CNY and a free cash flow of 49.44 million CNY. The capital expenditure of -864,500 CNY suggests the company is not currently investing heavily in new projects, which may indicate a focus on maintaining existing operations rather than aggressive expansion. The company's risk profile is moderate, with a medium liquidity risk and low dilution risk. The key flag of negative net cash after subtracting total debt suggests the company may need to manage its cash flow carefully to avoid liquidity constraints. However, the low dilution risk and minimal long-term debt indicate the company is not currently under pressure to issue new shares or take on additional debt. Recent events and filings have not been disclosed in the provided data, so no specific recent developments can be cited. The company's financials and risk profile suggest a stable and profitable operation, with a focus on maintaining liquidity and managing debt.